To the Point
Glaxo Will No Longer Pay Doctors to Promote Its Drugs
It's been standard practice for drug companies to pay doctors for promoting their products in speaking engagements and elsewhere, making some doctors rich but raising ethical questions. Now GlaxoSmithKline says it won't do that any more .
By Warren Olney • • 1 min readIt's been standard practice for drug companies to pay doctors for promoting their products in speaking engagements and elsewhere, making some doctors rich but raising ethical questions. Now GlaxoSmithKline says it won't do that any more. But today's announcement from the sixth largest drug company -- maker of Advair, Lovaza and other products -- may be evolutionary, rather than revolutionary. That's according to Charles Ornstein, senior reporter at ProPublica and past president of the Association of Health Care Journalists.
The full episode
3 of 3
Pope Francis Takes on 'Unfettered Capitalism'- 0:00What's Next for the Beleaguered NSA Surveillance Program
- 8:41Pope Francis: God and Money
- 45:18Glaxo Will No Longer Pay Doctors to Promote Its DrugsYou’re reading this
The full episode
3 of 3Pope Francis Takes on 'Unfettered Capitalism'- 0:00What's Next for the Beleaguered NSA Surveillance Program
- 8:41Pope Francis: God and Money
- 45:18Glaxo Will No Longer Pay Doctors to Promote Its DrugsYou’re reading this